Alcon
ALC · NYSE
Bulios Fair Price
$47.62
25.7% downside
Current Price
$64.11
According to Bulios Fair Price, ALC is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Alcon Inc. (ALC) is a global company operating in the field of ophthalmology and eye care. The company specializes in the development, manufacturing, and distribution of a wide range of eye products, including pharmaceuticals, medical devices, and surgical instruments. Alcon focuses on various eye conditions and issues, including cataracts, glaucoma, macular degeneration, and other eye diseases. Its products and technologies are used in both diagnosis and treatment of eye conditions, helping to improve vision and the quality of life for patients. Alcon has a long history and is recognized as a leader in the field of ophthalmology. The company continually strives to innovate and develop new technologies and treatment approaches to enhance eye care worldwide. Alcon Inc. (ALC) shares may be an attractive investment opportunity for investors interested in the healthcare sector and seeking an investment in a company specializing in ophthalmology and eye care.
Sector
Healthcare
Industry
Medical - Specialties
CEO
David J. Endicott
Employees
25,000
Headquarters
Geneva
Upcoming events
Earnings
Upcoming earnings report